Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratorio de Genetica e Diagnostico Molecular, |
RCV002244277 | SCV002512714 | uncertain significance | Hereditary lymphedema type I | 2021-06-03 | criteria provided, single submitter | clinical testing | ACMG classification criteria: BP4 supporting |
Ambry Genetics | RCV003093943 | SCV003677589 | uncertain significance | Inborn genetic diseases | 2022-07-14 | criteria provided, single submitter | clinical testing | The c.1093G>A (p.E365K) alteration is located in exon 8 (coding exon 8) of the FLT4 gene. This alteration results from a G to A substitution at nucleotide position 1093, causing the glutamic acid (E) at amino acid position 365 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |